SCHEMBL9760727

SCHEMBL9760727

COC(=O)C1=C(C)N(OC(=O)/C=C/C(=O)ON2C(C)=C(C(=O)OC)[C@H](c3ccccc3Cl)C(C(=O)OCC(C3CC3)C3CC3)=C2COCCOCCN)C(COCCOCCN)=C(C(=O)OCC(C2CC2)C2CC2)[C@H]1c1ccccc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 4/20 0.47
TBXA2R P21731 3/20 0.47
SLC6A3 Q01959 3/20 0.47
OPRM1 P35372 3/20 0.47
DRD3 P35462 3/20 0.47
KCNH2 Q12809 3/20 0.47
ABCB11 O95342 3/20 0.47
ABCB1 P08183 3/20 0.47
ADORA3 P0DMS8 3/20 0.47
SCN5A Q14524 3/20 0.47
CACNA1C Q13936 3/20 0.47
HTR1A P08908 2/20 0.47
ADRA2A P08913 2/20 0.47
CHRM1 P11229 2/20 0.47
DRD1 P21728 2/20 0.47
SLC6A2 P23975 2/20 0.47
ADRB3 P13945 2/20 0.47
OPRK1 P41145 2/20 0.47
HTR2B P41595 2/20 0.47
KCNK2 O95069 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9760259 0.95 HTR1A (0.46) ADRA1ATBXA2RSLC6A3OPRM1DRD3
SCHEMBL9761425 0.89 TBXA2R (0.59) ADRA1ATBXA2RSLC6A3OPRM1DRD3
SCHEMBL5459829 0.88 TBXA2R (0.60) ADRA1ATBXA2RSLC6A3OPRM1DRD3
SCHEMBL9761008 0.87 TBXA2R (0.39) ADRA1ATBXA2RSLC6A3OPRM1DRD3
SCHEMBL9760762 0.87 CACNA1C (0.43) ADRA1ATBXA2RSLC6A3OPRM1DRD3
SCHEMBL9759993 0.83 CYP2C9 (0.52) ADRA1ATBXA2RSLC6A3OPRM1DRD3
SCHEMBL9761327 0.82 PYGL (0.41) ADRA1ATBXA2RSLC6A3OPRM1DRD3
SCHEMBL9760067 0.81 TBXA2R (0.36) ADRA1ATBXA2RSLC6A3OPRM1DRD3
SCHEMBL9761225 0.81 CACNA1C (0.46) ADRA1ATBXA2RSLC6A3OPRM1DRD3
SCHEMBL7308054 0.81 TBXA2R (0.51) ADRA1ATBXA2RSLC6A3OPRM1DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5026863-A Medicinal products in racemic or enantiomorph form; calcium channel blockers. hypotensive agents, cardiovascular disorders ADIR ET COMPAGNIE (FR) 1991-06-25 US disclosed
US-4983740-A Multistep; from 2- 2-/2-chloroethoxy/ethoxy!ethanol and potassium phthalimide ADIR ET COMPAGNIE (FR) 1991-01-08 US disclosed
US-4870091-A CALCIUM CHANNEL BLOCKERS ADIR ET CIE (FR) 1989-09-26 US disclosed